メインコンテンツにスキップ
検索

早期臨床

登録

最新のリソース

注目コンテンツ

Upcoming early clinical webinars

Latest early clinical blogs

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法
How the US FDA MIDD paired pilot program helps sponsorsBlog

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法

指標となる臨床的薬剤相互作用研究における代謝物の測定
Measuring metabolites in index clinical DDI studiesBlog

指標となる臨床的薬剤相互作用研究における代謝物の測定

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters
Why FDA’s omaveloxolone approval for Friedreich’s ataxia mattersBlog

Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters

Key development considerations for cell therapies
Key development considerations for cell therapiesBlog

Key development considerations for cell therapies

医薬品開発のリスク軽減：早期開発における重要な化学、製造、および管理（CMC）および生理学的薬物動態（PBPK）アプローチ
De-risking drug development: Key chemistry, manufacturing, and controls (CMC) and physiologically based pharmacokinetic (PBPK) approaches in early developmentBlog

医薬品開発のリスク軽減：早期開発における重要な化学、製造、および管理（CMC）および生理学的薬物動態（PBPK）アプローチ

Shining a spotlight on clinical study software at the 2024 Pinnacle 21 Enterprise user group meeting
Shining a spotlight on clinical study software at the 2024 Pinnacle 21 Enterprise user group meetingBlog

Shining a spotlight on clinical study software at the 2024 Pinnacle 21 Enterprise user group meeting

以下のイベントで弊社のエキスパートをご紹介

All early clinical resources

Exploratory data analyses of a drug-biomarker efficacy PD model

Certara University, Modeling and Simulation - PK/PD, Webinar

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Webinar

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Clinical Pharmacology, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

基本的なバリデーションの、その先へ：Pinnacle 21 Enterpriseで、申請対応可能なデータセットを実現

CDISC, Certara Products - Pinnacle 21, Fact Sheet

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

AI & Machine Learning, Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Certara Services, Clinical Pharmacology, Drug Development, Infectious Disease, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Publication

Important drug development questions that model-based meta-analysis answers

Certara Services, Clinical Pharmacology, Drug Development Support, Model Informed Drug Development, Modeling and Simulation - MBMA, Blog

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech]

Certara Products - Pinnacle 21, Certara Products - SEND Explorer, Data Standards, Webinar

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

Biologics, Certara Products - Certara IQ, Modeling and Simulation, Modeling and Simulation - QSP, Publication

EANM 2026

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Webinar

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

Certara Products - Phoenix, Model Informed Drug Development, Modeling and Simulation - PK/PD, Blog
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software